mHealth Interventions for Smoking Cessation
(Project mFLi Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new mobile health (mHealth) tools to help cancer patients quit smoking. By testing an app-based treatment against a traditional quitline treatment, researchers aim to determine which method more effectively aids smoking cessation. The study will also use data to enhance future tools through advanced technology like machine learning, which learns from data. Candidates may be suitable if they are cancer patients who have smoked at least 100 cigarettes in their lifetime, currently smoke, have access to a smartphone, and seek support to quit smoking. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could improve future smoking cessation tools for cancer patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these mHealth interventions are safe for cancer patients?
Research has shown that treatments using apps to help people quit smoking are generally easy to use and well-liked. One study found that a mobile app for quitting smoking was popular and user-friendly, meaning people found it simple to use and were satisfied with it. Studies have reported no major safety issues.
For the Quitline treatment, research also indicates it is well-received. Many people participate in the program and receive additional support, such as medications to stop smoking. Quitlines have consistently supported those who want to quit smoking, with no significant safety problems reported.
Both app-based and Quitline treatments are safe ways to help people quit smoking, with users generally responding positively to these methods.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to help cancer patients quit smoking. Unlike traditional methods, such as nicotine replacement therapy or prescription medications, this trial is testing an app-based treatment that delivers smoking cessation support directly to a person's smartphone. The app aims to make help more accessible and convenient, potentially reaching patients who might not seek traditional face-to-face options. Additionally, the study uses machine learning to analyze data, which could lead to more personalized and effective treatment strategies in the future. This approach could revolutionize how smoking cessation support is delivered, making it more adaptable to individual needs.
What evidence suggests that this trial's treatments could be effective for smoking cessation in cancer patients?
Research has shown that mobile health (mHealth) apps can significantly aid people in quitting smoking. Studies have found that smartphone apps can increase the chances of quitting. In some cases, these technology-based methods have raised the number of people who remain smoke-free by up to 88% after six months. In this trial, some participants will receive the App-based Treatment (mHealth). Similarly, Quitline services, which provide phone support, have also proven effective. One study found that 23.3% of people who used Quitline remained smoke-free after 12 months. Other participants in this trial will receive the Quitline Treatment (QT). Both mHealth apps and Quitline services are promising tools for helping cancer patients quit smoking.678910
Who Is on the Research Team?
Damon Vidrine, DrPH
Principal Investigator
Moffitt Cancer Center
Vani Simmons, PhD
Principal Investigator
Moffitt Cancer Center
Are You a Good Fit for This Trial?
This trial is for English-speaking cancer patients who have smoked at least 100 cigarettes in their lifetime, currently smoke, own a working smartphone, and are 18 or older. Pregnant or breastfeeding individuals, or those who don't confirm participation electronically within two weeks of being chosen, cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Quitline or Mobile-Delivered Smoking Cessation Intervention
Follow-up
Participants are monitored for usability, acceptability, and satisfaction of the mHealth intervention
What Are the Treatments Tested in This Trial?
Interventions
- App-based Treatment (mHealth)
- Quitline Treatment (QT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
H. Lee Moffitt Cancer Center and Research Institute
Lead Sponsor
Florida Biomedical Research Program - James & Esther King
Collaborator